γ-Core Guided Antibiotic Design Based on Human Enteric Defensin 5.

Area of Science:

• Biochemistry
• Microbiology
• Drug Discovery

Background:

• Rising antibiotic resistance necessitates novel antibacterial agents.
• Human defensin 5 (HD5) possesses broad-spectrum antimicrobial properties but is challenging to synthesize.
• The conserved γ-core motif of HD5 is crucial for its antibacterial function.

Purpose of the Study:

• To engineer a potent and synthetically accessible analog of HD5.
• To investigate the structure-activity relationship of HD5 derivatives.
• To evaluate the efficacy of the novel peptide RC18 against methicillin-resistant Staphylococcus aureus (MRSA).

Main Methods:

• Truncation of HD5 to isolate the γ-core motif.
• Introduction of disulfide bonds and amino acid substitutions (Glu/Ser to Arg) to create RC18.
• Structure-activity relationship studies, bacterial membrane penetration assays, molecular dynamics simulations, and in vivo infection models.

Main Results:

• The γ-core motif required specific spatial conformation for antibacterial activity.
• RC18, with enhanced disulfide bonds and arginine residues, demonstrated superior potency against MRSA compared to HD5.
• RC18 exhibited increased binding affinity to lipid A and lipoteichoic acid, enhanced bacterial membrane penetration, and improved survival rates in infected mice.

Conclusions:

• RC18 is a promising therapeutic candidate for treating MRSA infections.
• The modified defensin peptide effectively reduces bacterial colonization and enhances host survival.
• Strategic structural modifications can yield potent antimicrobial peptides with improved therapeutic potential.